Medicine Compliance Aid Stability
GalvusNovartis Pharmaceuticals UK Ltd
Novartis Pharmaceuticals UK Ltd
A3 · Amber 3 No stability data is available. There are theoretical concerns with use in CAs, which may be mitigated by risk minimisation.
Protect from moisture
Protect from moisture.
23 January 2015